Cognition, Behavior, and Psychosocial Effects of Seizures in the Developing Brain

Katerina Lin1, Carl E Stafstrom2

  • 1Division of Pediatric Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Insights

Epilepsy significantly impacts brain development, causing comorbidities like cognitive and behavioral issues. This study explores seizure-related impacts and potential interventions for neurodevelopmental support.

Area of Science:

  • Neurology
  • Neuroscience
  • Developmental Biology

Background:

  • Epilepsy, characterized by recurrent seizures, profoundly affects the developing brain.
  • Patients often experience comorbidities impacting cognition, behavior, and mental health, sometimes causing more distress than epilepsy itself.

Purpose of the Study:

  • To investigate the relationship between seizures and the development of comorbidities.
  • To explore neurobiological mechanisms linking seizures to cognitive and behavioral outcomes.
  • To highlight potential interventions for neurodevelopmental support in individuals with epilepsy.

Main Methods:

  • Review of current clinical and basic science research methodologies.
  • Exploration of neurobiological pathways involved in seizure generation and associated outcomes.

Main Results:

  • Epilepsy and its seizures are linked to significant cognitive, behavioral, and psychiatric comorbidities.
  • Understanding the neurobiological underpinnings is crucial for developing targeted interventions.

Conclusions:

  • Interventions targeting neurodevelopmental progress are essential for individuals with epilepsy.
  • Further research into seizure-related comorbidities can optimize patient care and support.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
900
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.0K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
617
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
403